Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report

Purpose. To present the case of a 27-year-old male patient with stage IV proliferative sickle cell retinopathy, treated with one intravitreal injection of ranibizumab, showing regression of the neovascularization and no recurrence at the 9-month follow-up. Methods. A 27-year-old male patient present...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Ophthalmol Med
Main Authors: Mitropoulos, Panagiotis G., Chatziralli, Irini P., Parikakis, Efstratios A., Peponis, Vasileios G., Amariotakis, Georgios A., Moschos, Marilita M.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4258923/
https://ncbi.nlm.nih.gov/pubmed/25506450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/682583
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados